Product
Recombinant Hepatitis B Vaccine
1 clinical trial
2 indications
Indication
HandIndication
Foot-and-Mouth DiseaseClinical trial
Study on the Immunogenicity and Safety of Inactivated Enterovirus Type 71 Vaccine Combined Administration With Recombinant Hepatitis B and Group A Meningococcal VaccineStatus: Active (not recruiting), Estimated PCD: 2024-12-31